Small bowel obstruction

A 58-year-old arrives at 02:00 with colicky central pain, four vomits and absolute constipation, thirty months after an open right hemicolectomy. Every decision you will make for her — CT now or plain film, Gastrografin tonight or tomorrow, theatre now or a 72-hour trial, and laparoscopy or laparotomy when the trial fails — is mapped by the Bologna and EAST guidelines and by a small set of trials and cohorts whose numbers examiners expect you to quote. This page attaches those numbers to each decision.^[1][3]

Definition and the classifications that matter

Small bowel obstruction is the failure of aboral transit of intestinal content through the small bowel, and in adults it is most commonly due to occlusion of the lumen with proximal fluid and gas accumulation that may progress to mucosal ischaemia, necrosis and perforation.^[8] Three overlapping classifications organise every management conversation:

• Partial versus complete. Partial obstruction still allows some content and gas to pass; complete obstruction does not. EAST is explicit that both partial and complete SBO can safely undergo initial non-operative management once the danger features are excluded — completeness alone is not an indication for theatre.^[3]
• Simple versus strangulated (complicated). Strangulation means the blood supply is compromised: the bowel is ischaemic, on the way to necrosis and perforation. This is the dichotomy that decides who can wait.^[8][10]
• Open versus closed loop. A closed loop is obstructed at two points, so the segment cannot decompress in either direction; it is the mechanism most tightly linked to ischaemia — in the Zielinski derivation cohort, closed loop obstruction was seen in 27% of ischaemic cases versus 2% of non-ischaemic ones.^[14]

The AAST anatomic severity grade formalises severity for adhesive SBO into five grades assigned from imaging or operative findings: grade I partial SBO; grade II complete SBO with viable, uncompromised bowel; grade III complete SBO with compromised but viable bowel; grade IV complete SBO with nonviable bowel or perforation with localised spillage; grade V small-bowel perforation with diffuse peritoneal contamination.^[21] The grade is not decorative: in the EAST multi-institutional validation of 635 patients, increasing grade was associated with longer stay, need for intensive care, more complications and higher Clavien-Dindo grade, and with conversion to open surgery, bowel resection, temporary abdominal closure and stoma creation.^[21]

Epidemiology — and the aetiology league table

SBO represents as many as 16% of surgical admissions and more than 300,000 operations annually in the United States.^[3] The cause list every examiner wants, from the Miller series of 1,001 admissions: adhesions 74%, Crohn's disease 7%, neoplasia 5%, hernia 2%, radiation 1%, miscellaneous 11%.^[4] The contemporary multinational SnapSBO cohort (1,737 patients with SBO) shows the same dominance with a different denominator: adhesions 56.7%, hernia 25.9%, malignancy 9.2%, strictures 6.3%.^[25]

The reason adhesions dominate is measurable. In the original SCAR study of 12,584 patients undergoing open lower abdominal surgery, 32.6% were readmitted a mean of 2.2 times over ten years for a potential adhesion-related problem.^[5] The SCAR update followed 72,270 patients and found that laparoscopy cuts the bill but does not abolish it: 1.7% of laparoscopic versus 4.3% of open-surgery patients were readmitted within 5 years for disorders directly related to adhesions — a 32% relative reduction in directly related readmissions (HR 0.68).^[6]

Pathophysiology — one blockage, two clocks

Proximal to the occlusion, swallowed air and secreted fluid accumulate; the bowel distends; vomiting and sequestration dehydrate the patient and derange electrolytes. This is the clock you treat with nasogastric decompression and intravenous fluids.^[1][8] The second clock is mechanical and vascular: a simple obstruction may sit for days without bowel injury, but a strangulated obstruction — classically a closed loop — compromises the circulation and progresses through mucosal ischaemia to necrosis and perforation.^[8][14] The entire diagnostic apparatus of this page exists to read the second clock before the bowel dies, because management has shifted from immediate surgery to non-operative treatment in the absence of ischaemia.^[10]

Adhesions themselves are the footprints of previous abdominal procedures, and their prevention is now a named part of the guideline: minimally invasive techniques and adhesion barriers reduce formation, and the 2026 WSES narrative bundles prevention as — whenever possible, minimally invasive surgery; good surgical technique; and barriers.^[1][7] The 2013 Bologna update is specific about the barrier evidence: hyaluronic acid-carboxycellulose membrane and icodextrin decrease the incidence of adhesions, icodextrin may reduce the risk of re-obstruction, and the membrane cannot reduce the need for surgery.^[2]

Clinical presentation — what the bedside can and cannot tell you

The meta-analysis of history and examination is humbling and quotable: the useful findings are limited to a history of abdominal surgery, constipation, abnormal bowel sounds and abdominal distension.^[9] The emergency-medicine evidence review adds the strangulation list: fever, hypotension, diffuse abdominal pain and peritonitis.^[8] EAST operationalises the same idea as clinical deterioration — fever, leukocytosis, tachycardia, metabolic acidosis and continuous pain — any of which, or ischaemia on imaging, mandates timely exploration.^[3]

Investigations and the imaging pathway

Plain radiography is the least useful test: pooled positive likelihood ratio 1.64 in the Taylor and Lalani meta-analysis, against 3.6 for CT and 6.77 for MRI, with ultrasound performing best where operator skill exists.^[9] EAST accordingly assigns Level I evidence to CT — specifically multidetector CT with multiplanar reconstructions — because it adds clinically relevant information over plain films that changes management.^[3] Bologna names CT the technique of choice whenever the adhesive aetiology is unsure or contraindications to non-operative management might be present.^[1] What CT establishes, per the Radiology review: confirmation of mechanical SBO, the site, the cause, and the complications.^[10]

^[2]

The CT signs of strangulation — learn them by weight

The Millet combined model is the centrepiece: in 256 consecutive adhesive SBO patients with surgical reference standards, three CT findings independently predicted strangulation — reduced bowel wall enhancement (OR 7.8), diffuse mesenteric haziness (OR 6.1) and a closed-loop mechanism (OR 6.5) — and the three-sign score reached an area under the curve of 0.91 with a negative predictive value of 97%.^[11] Among strangulated cases, reduced enhancement (OR 3.9) and mesenteric fluid (OR 3.6) predicted the need for resection.^[11]

The earlier meta-analysis of nine studies (768 patients, 205 with strangulation) assigns the roles cleanly: reduced bowel wall enhancement is the most specific sign (specificity 95%, positive likelihood ratio 11.07), while the absence of mesenteric fluid is the ruling-out sign (sensitivity 89%, negative likelihood ratio 0.16). Bowel wall thickening itself is weak (sensitivity 48%).^[12] And for closed-loop obstruction specifically, increased unenhanced bowel-wall attenuation — the wall that looks too bright before contrast — was the only sign associated with necrosis: 100% specific, 58% sensitive, and an indication for prompt surgery.^[13]

Who needs an operation — the Zielinski models

Zielinski's derivation (100 patients, blinded CT review) found four independent predictors of needing exploration: free intraperitoneal fluid (OR 3.80), mesenteric oedema (OR 3.59), absence of the small-bowel faeces sign (OR 0.19 for its presence — the faeces sign is protective), and a history of vomiting (OR 4.67).^[14] The prospective validation refined this to a simpler three-feature model — mesenteric oedema (OR 5.6), lack of the small-bowel faeces sign (OR 5.1) and obstipation (OR 3.2), concordance index 0.77 — and advises that when all three are present, early exploration deserves strong consideration.^[15] These are precisely the CT signs Bologna lists as contraindicating non-operative management: free fluid, mesenteric oedema, the faeces sign and devascularisation.^[2]

Non-operative management and the Gastrografin challenge

^[1]

The Bologna principles of non-operative treatment are nil per os, nasogastric or long-tube decompression, and intravenous fluids and electrolytes; the contraindications are peritonitis, strangulation and ischaemia.^[1] Water-soluble contrast (Gastrografin) can be given orally or via the nasogastric tube, immediately at admission or after 48 hours of failed conservative treatment; the radiologic appearance of contrast in the colon within 24 hours predicts resolution.^[2] EAST frames it from the other direction: consider water-soluble contrast studies in patients who have not clinically resolved after 48 to 72 hours, for both diagnostic and potential therapeutic purposes.^[3]

What the test predicts. In the Cochrane review, contrast in the colon on an abdominal X-ray within 24 hours predicts resolution with pooled sensitivity 0.97 and specificity 0.96 — area under the summary ROC curve 0.98.^[16]

What the drug does — quote the conflict honestly. Cochrane (six RCTs): water-soluble contrast did not reduce the need for surgical intervention (OR 0.81, p = 0.3) but reduced hospital stay (weighted mean difference −1.83 days); the authors state plainly that Gastrografin does not cause resolution.^[16] The 2020 RCT meta-analysis (nine trials, 879 patients) found the stay effect shrunk to a clinically insignificant −0.15 days with no effect on surgery or mortality.^[17] The 2022 Annals of Surgery meta-analysis (11 RCTs, 817 patients; plus 9 observational studies) lands between: length of stay in non-surgical patients fell by 1.95 days in the RCTs, operative rates were unchanged in RCTs (19.8% vs 21.4%) but lower in the observational data (11% vs 16%, RR 0.56) — and the authors conclude the literature is heterogeneous and high-quality RCTs with standardised protocols are needed.^[18] The defensible fellowship position: Gastrografin is a predictive test first, with a probable modest therapeutic effect on resolution speed rather than on the need for surgery.^[16][18]

The 72-hour ceiling. Non-operative management, in the absence of strangulation or peritonitis, can be prolonged up to 72 hours; after 72 hours without resolution, surgery is recommended.^[2] The ceiling is not arbitrary. SnapSBO shows what the pathways cost: successful NOM patients stayed a mean of 5.3 days and 61.0% achieved the optimal-outcome composite; patients who went to theatre after a failed trial stayed 12.9 days with only 16.1% optimal outcomes; direct-to-surgery patients sat between at 7.7 days and 37.6%.^[25] And in the multinational AAST cohort, failing non-operative management was itself an independent predictor of mortality (OR 2.4).^[22] A failed trial that drifts is the worst of both worlds.

^{[25] [2]}

Operative management — when and how

Timely exploration — not a non-operative trial — is mandated for generalized peritonitis, clinical deterioration, or ischaemia on imaging.^[3] Open surgery remains the default for strangulating obstruction and after failed conservative treatment, but for selected patients the laparoscopic approach is advisable, and the 2013 Bologna technical rules are worth reproducing verbatim in a viva: open access technique; entry in the left upper quadrant or left flank; lyse only the completely obstructing adhesions, with cold scissors; attempt laparoscopy preferably for a first episode or an anticipated single band; and keep a low threshold for conversion.^[2]

LASSO is the trial to quote: 104 patients whose adhesive SBO had not resolved with conservative management, randomised to open or laparoscopic adhesiolysis across eight Finnish and Italian hospitals, restricted to patients with a high likelihood of a single adhesive band. Postoperative stay was 1.3 days shorter after laparoscopy (geometric mean 5.5 vs 4.2 days; ratio 1.31, p = 0.013), with complications 43% versus 31% (OR 0.61, p = 0.23) and one death in each group — laparoscopic adhesiolysis provides quicker recovery in selected patients.^[19] The 2020 meta-analysis of 14 studies and 37,007 participants keeps the claim honest: in the primary matched analysis, laparoscopy was neither better nor worse for mortality, iatrogenic perforation, stay, severe complications or readmission — safe and feasible, with the research frontier in patient selection.^[20] Bologna 2017 states the same conclusion: a laparoscopic approach may be beneficial for selected cases of simple ASBO.^[1]

The AAST grading — say it like a classification, use it like a prognostic score

The grade definitions appear in the classification section; the validation numbers are what examiners test. In the EAST multi-institutional prospective observational study of 635 adhesive SBO patients, the grade distribution was I 60.5%, II 21.2%, III 9.2%, IV 8.6%, and increasing grade predicted conversion to open surgery, small-bowel resection, temporary abdominal closure and stoma creation.^[21] The multinational application — 789 patients across Minnesota, Bologna, Pietermaritzburg and Bucharest — found successful non-operative management in 58%, a 33% laparoscopy-to-laparotomy conversion rate, 2% overall mortality, and independent mortality predictors of grade III (OR 4.4), grade IV (OR 7.4), pneumonia (OR 5.6) and failed non-operative management (OR 2.4).^[22] The practical translation: grade III and IV disease is where the mortality lives, and a patient climbing the grades on serial review is a patient who needs theatre.

Recurrence, prognosis and the honest counselling conversation

The Fevang cohort — 500 patients operated for adhesive obstruction, followed up to 40 years — gives the numbers to counsel with: cumulative recurrence after one operation was 18% at 10 years and 29% at 30 years; for patients with four or more ASBO admissions the cumulative recurrence reached 81%; most recurrences occur within 5 years, but a considerable risk persists 10 to 20 years out.^[23] The trade-off to state without flinching, from Bologna 2013: patients treated non-operatively have a shorter hospital stay but a higher recurrence rate and a shorter time to readmission, although the risk of new surgically treated episodes is unchanged; the recurrence risk factors are age under 40 and matted adhesions.^[2] Surgery reduces future admissions but not the risk of new surgically treated episodes — an operation for ASBO does not cure the tendency to obstruct.^[23] Younger patients, with a higher lifetime recurrence risk, are the group Bologna singles out for adhesion barriers as primary and secondary prevention.^[1]

Special populations and named traps

The virgin abdomen. Surgical dogma mandated exploration for SBO without previous surgery, on the assumption that adhesions cannot exist and a sinister cause must. Collom's EAST multicentre analysis deconstructs this: in 601 SBO patients (101 without prior surgery), previous surgery (OR 0.47) and Gastrografin use (OR 0.11) independently predicted successful non-operative management, and Gastrografin reduced operative exploration in patients with and without prior surgery — the authors recommend that SBO in a virgin abdomen be considered for the Gastrografin-based non-operative approach.^[24] The caveat is in their exclusion criteria, and you should quote them: hypotension, strangulation, peritonitis, closed loop obstruction and pneumatosis were excluded — the dogma falls only after the danger screen is passed.^[24]

Hernias. Never forget the groins and the old scars: hernias cause a quarter of SBO in the SnapSBO distribution, and in the Miller series the hernia group was the one exception where non-operative treatment carried a higher recurrence rate.^[25][4]

Evidence deserts. Bologna 2017 states explicitly that scientific evidence for aspects of ASBO management is scarce, particularly for special patient groups; where the evidence runs out, say so rather than inventing a rule.^[1]

Revision summary

• Classify first: partial versus complete, simple versus strangulated, open versus closed loop — then grade with AAST I–V.^[8][21]
• CT with multiplanar reconstruction is the Level I test; reduced enhancement rules ischaemia in (LR+ 11), absent mesenteric fluid rules strangulation out, and the Millet three-sign score (reduced enhancement, mesenteric haziness, closed loop) has a 97% NPV.^[3][11][12]
• Peritonitis, deterioration or CT ischaemia → timely exploration; everyone else → nil per os, NG decompression, IV fluids and a water-soluble contrast challenge; contrast in the colon within 24 hours predicts resolution (sensitivity 0.97, specificity 0.96).^[1][3][16]
• Gastrografin does not reduce the need for surgery in the RCTs; its stay effect ranges from 1.95 days down to a clinically insignificant 0.15 days depending on the meta-analysis — call it predictive first, therapeutic second.^[16][17][18]
• The NOM ceiling is 72 hours; failed NOM costs days (12.9 vs 5.3) and is an independent mortality predictor (OR 2.4).^[2][22][25]
• Laparoscopic adhesiolysis is for selected single-band disease — LASSO: 1.3 days shorter stay — with open access, left upper quadrant entry, cold scissors and a low threshold for conversion.^[19][2]
• Counsel recurrence honestly: 18% at 10 years, 29% at 30, 81% after four episodes; NOM shortens stay but raises recurrence, and no treatment removes the risk.^[23][2]
• The virgin abdomen can be managed non-operatively with Gastrografin — after strangulation, peritonitis, closed loop and pneumatosis are excluded.^[24]

References25ShowHide

1. [1]Ten Broek RPG, Krielen P, Di Saverio S, Coccolini F, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg, 2018.PMID 29946347
2. [2]Di Saverio S, Coccolini F, Galati M, Smerieri N, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg, 2013.PMID 24112637
3. [3]Maung AA, Johnson DC, Piper GL, Barbosa RR, et al. Evaluation and management of small-bowel obstruction: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg, 2012.PMID 23114494
4. [4]Miller G, Boman J, Shrier I, Gordon PH Etiology of small bowel obstruction. Am J Surg, 2000.PMID 11036136
5. [5]Parker MC, Ellis H, Moran BJ, Thompson JN, et al. Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum, 2001.PMID 11391142
6. [6]Krielen P, Stommel MWJ, Pargmae P, Bouvy ND, et al. Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update). Lancet, 2020.PMID 31908284
7. [7]Neo JWQ, Broek RPGT, Mathur S, Catena F, et al. Pathophysiology, prevention and treatment of postoperative peritoneal adhesions: a WSES narrative. World J Emerg Surg, 2026.PMID 42393727
8. [8]Long B, Robertson J, Koyfman A Emergency Medicine Evaluation and Management of Small Bowel Obstruction: Evidence-Based Recommendations. J Emerg Med, 2019.PMID 30527563
9. [9]Taylor MR, Lalani N Adult small bowel obstruction. Acad Emerg Med, 2013.PMID 23758299
10. [10]Zins M, Millet I, Taourel P Adhesive Small Bowel Obstruction: Predictive Radiology to Improve Patient Management. Radiology, 2020.PMID 32692296
11. [11]Millet I, Boutot D, Faget C, Pages-Bouic E, et al. Assessment of Strangulation in Adhesive Small Bowel Obstruction on the Basis of Combined CT Findings: Implications for Clinical Care. Radiology, 2017.PMID 28759326
12. [12]Millet I, Taourel P, Ruyer A, Molinari N Value of CT findings to predict surgical ischemia in small bowel obstruction: A systematic review and meta-analysis. Eur Radiol, 2015.PMID 25850889
13. [13]Rondenet C, Millet I, Corno L, Boulay-Coletta I, et al. Increased unenhanced bowel-wall attenuation: a specific sign of bowel necrosis in closed-loop small-bowel obstruction. Eur Radiol, 2018.PMID 29679213
14. [14]Zielinski MD, Eiken PW, Bannon MP, Heller SF, et al. Small bowel obstruction-who needs an operation? A multivariate prediction model. World J Surg, 2010.PMID 20217412
15. [15]Zielinski MD, Eiken PW, Heller SF, Lohse CM, et al. Prospective, observational validation of a multivariate small-bowel obstruction model to predict the need for operative intervention. J Am Coll Surg, 2011.PMID 21458305
16. [16]Abbas S, Bissett IP, Parry BR Oral water soluble contrast for the management of adhesive small bowel obstruction. Cochrane Database Syst Rev, 2007.PMID 17636770
17. [17]Koh A, Adiamah A, Chowdhury A, Mohiuddin MK, et al. Therapeutic Role of Water-Soluble Contrast Media in Adhesive Small Bowel Obstruction: a Systematic Review and Meta-Analysis. J Gastrointest Surg, 2020.PMID 31485900
18. [18]Klingbeil KD, Wu JX, Osuna-Garcia A, Livingston EH The Effect of Hyperosmolar Water-Soluble Contrast for the Management of Adhesive Small Bowel Obstruction: A Systematic Review and Meta-Analysis. Ann Surg, 2022.PMID 35837888
19. [19]Sallinen V, Di Saverio S, Haukijärvi E, Juusela R, et al. Laparoscopic versus open adhesiolysis for adhesive small bowel obstruction (LASSO): an international, multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol, 2019.PMID 30765264
20. [20]Krielen P, Di Saverio S, Ten Broek R, Renzi C, et al. Laparoscopic versus open approach for adhesive small bowel obstruction, a systematic review and meta-analysis of short term outcomes. J Trauma Acute Care Surg, 2020.PMID 32195994
21. [21]Hernandez MC, Haddad NN, Cullinane DC, Yeh DD, et al. The American Association for the Surgery of Trauma Severity Grade is valid and generalizable in adhesive small bowel obstruction. J Trauma Acute Care Surg, 2018.PMID 29117026
22. [22]Hernandez MC, Birindelli A, Bruce JL, Buitendag JJP, et al. Application of the AAST EGS Grade for Adhesive Small Bowel Obstruction to a Multi-national Patient Population. World J Surg, 2018.PMID 29770872
23. [23]Fevang BT, Fevang J, Lie SA, Søreide O, et al. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg, 2004.PMID 15273540
24. [24]Collom ML, Duane TM, Campbell-Furtick M, Moore BJ, et al. Deconstructing dogma: Nonoperative management of small bowel obstruction in the virgin abdomen. J Trauma Acute Care Surg, 2018.PMID 29965940
25. [25]Kaplan LJ, Martinez-Casas I, Mohseni S, Cimino M, et al. Small bowel obstruction outcomes according to compliance with the World Society of Emergency Surgery Bologna guidelines. Br J Surg, 2025.PMID 40246692